LEP and prostate carcinoma: 746 potentially eligible studies were identified, 610 were clearly ineligible (they were genetic, in vivo, in vitro or biochemical studies, reviews, commentaries or duplicates or did not report on the associations of adiponectin or leptin with prostate cancer) therefore 137 publications were retrieved.